/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-12-02 12:51:592016-11-28 12:52:25SuperGen to Present Data at the 50th ASH Annual Meeting & Exposition
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-12-01 12:52:342016-11-28 12:52:57Astex presents updates on AT7519 and AT9283 at the American Society of Hematology (ASH) Conference
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-11-20 12:53:072016-11-28 12:53:41SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-10-23 12:55:182016-11-28 12:55:40SuperGen’s MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-10-15 12:55:492016-11-28 12:56:10SuperGen to Present Data at EORTC-NCI-AACR
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-09-29 12:56:182016-11-28 12:56:42Cancer Research UK and Astex Therapeutics Join Forces to Develop New Anti-Cancer Treatment
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-08-07 12:56:522016-11-28 12:57:13SuperGen Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
